free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

  • Biosight Receives Orphan Drug Designation for BST-236 for AML americanpharmaceuticalreview
    June 06, 2019
    Biosight announced the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to?BST-236, an investigational novel antimetabolite, for the treatment of acute myeloid leukemia (AML).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service